Acadia Pharmaceuticals Inc (ACAD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ACAD? Forum Prognose

Finanzdaten der Acadia Pharmaceuticals Inc-Aktie (ACAD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.91% 205.83	231.04	211.70	165.24	118.46
Cost Of Revenue	28.29% 22.95	17.89	14.62	7.459	1.667
Gross Profit	14.20% 182.88	213.15	197.08	157.78	116.80
Operating Expenses	5.91% 167.67	178.21	254.85	154.74	170.38
Benefits Costs and Expenses	184.83	-	-	-	-
Costs And Expenses	190.62	-	269.48	162.20	172.05
Operating Income/Loss	56.47% 15.21	34.94	-57.78	3.037	-53.58
Income/Loss From Continuing Operations Before Tax	90.91% 21.00	231.04	-52.14	6.343	-44.94
Income Tax Expense/Benefit	172.97% 4.447	-6.094	13.03	5.229	-1.918
Income/Loss From Continuing Operations After Tax	63.85% 16.55	45.80	-65.18	1.114	-43.02
Net Income/Loss	63.85% 16.55	45.80	-65.18	1.114	-43.02
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	49.79M% 164.80	0.000331	0.1642	0.1635	162.26
Diluted Average Shares	50.34M% 166.62	0.000331	0.1642	0.165	162.26
Basic Earnings Per Share	64.29% 0.10	0.28	-0.40	0.01	-0.27
Diluted Earnings Per Share	64.29% 0.10	0.28	-0.40	0.01	-0.27
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%